US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novartis AG

131.43

+0.66000.50%

Post-market: 131.430.00000.00%19:51 EDT

Volume:1.33M

Turnover:174.38M

Market Cap:254.43B

PE:19.19

High:132.44

Open:130.57

Low:130.41

Close:130.77

52wk High:133.55

52wk Low:96.06

Shares:1.94B

Float Shares:1.84B

Volume Ratio:0.78

T/O Rate:0.07%

Dividend:3.86

Dividend Rate:2.94%

EPS(TTM):6.85

EPS(LYR):5.92

ROE:32.49%

ROA:11.88%

PB:6.06

PE(LYR):22.21

Loading ...

Overview Company News Filings

Nyse Order Imbalance 90059.0 Shares on Sell Side

THOMSON REUTERS

Novartis Says 5-Year Kisqali Data Cut Early Breast Cancer Recurrence by 28%

MT Newswires Live

Novartis Says European Regulator Backs Expanded Use of Blood Cancer Drug

MT Newswires Live

Novartis Scemblix receives positive CHMP opinion for Scemblix

Small-Cap Biotech Climb Bio's Lead Drug Candidate Has Larger Long-Term Opportunity

Novartis' Phase 3 Study of Fabhalta in IgA Nephropathy Meets Primary Endpoint

MT Newswires Live

Novartis announces Phase III study of Fabhalta showed superiority to placebo

Novartis Growth Should Normalize After Successful Turnaround -- Market Talk

Novartis Growth Likely to Stall on Cosentyx Sales Slide -- Market Talk

Pharma Shares Rally. Eli Lilly Up Nearly 3%; Novo, Johnson & Johnson Up Around 2%; Sanofi, Pfizer, Astrazeneca Up Over 1%

Tiger Newspress

Immatics Names Venkat Ramanan CFO

MT Newswires Live

Novartis Receives FDA Approval for Skin Condition Treatment

MT Newswires Live

Novartis Bags First FDA Approval for Rhapsido, More Could Follow -- Market Talk

Novartis announces FDA approval of Rhapsido for treatment of CSU

Pharma's Direct-To-Patient Wave Hits Novartis Next

Benzinga_recent_news

Novartis to launch direct-to-patient platform for Cosentyx in U.S.

European Equities Close Higher in Friday Trading; Eurozone Consumer Inflation Expectations Rise

MT Newswires Live

Amneal Pharmaceuticals Files Biologics License Application for Xolair Biosimilar

MT Newswires Live

Novartis Says Won't be Impacted by 100% Tariff on Branded Pharmaceutical Products

MT Newswires Live

U.S. Tariffs Pose Limited Risk to Big Swiss Pharma Groups -- Market Talk

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NVS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NVS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVS\",,,,,undefined,":{"symbol":"NVS","market":"US","secType":"STK","nameCN":"Novartis AG","latestPrice":131.43,"timestamp":1760731200000,"preClose":130.77,"halted":0,"volume":1326320,"hourTrading":{"tag":"盘后","latestPrice":131.43,"preClose":131.43,"latestTime":"19:51 EDT","volume":22004,"amount":2891979.5,"timestamp":1760745063395},"delay":0,"floatShares":1843882545,"shares":1935853188,"eps":6.849934,"marketStatus":"Market Closed","change":0.66,"latestTime":"10-17 16:00:00 EDT","open":130.57,"high":132.44,"low":130.41,"amount":174377404.73520002,"amplitude":0.015523,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":6.849934,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760947200000},"marketStatusCode":7,"adr":1,"adrRate":1,"exchange":"NYSE","adjPreClose":130.77,"dividendRate":0.029387,"preHourTrading":{"tag":"盘前","latestPrice":130.58,"preClose":130.77,"latestTime":"09:24 EDT","volume":87283,"amount":11412148.383229999,"timestamp":1760707487258},"postHourTrading":{"tag":"盘后","latestPrice":131.43,"preClose":131.43,"latestTime":"19:51 EDT","volume":22004,"amount":2891979.5,"timestamp":1760745063395},"volumeRatio":0.7832211794545764,"impliedVol":0.2381,"impliedVolPercentile":0.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NVS\",,,,,undefined,":{"symbol":"NVS","floatShares":1843882545,"roa":"11.88%","roe":"32.49%","lyrEps":5.916419,"volumeRatio":0.7832211794545764,"shares":1935853188,"dividePrice":3.862367,"high":132.44,"amplitude":0.015523,"preClose":130.77,"low":130.41,"week52Low":96.062,"pbRate":"6.06","psRate":"4.61","week52High":133.55,"institutionHeld":0.053,"latestPrice":131.43,"eps":6.849934,"divideRate":0.029387,"volume":1326320,"delay":0,"ttmEps":6.849934,"open":130.57,"prevYearClose":97.31,"prevWeekClose":130.03,"prevMonthClose":128.24,"prevQuarterClose":128.24,"fiveDayClose":130.03,"twentyDayClose":122.93,"sixtyDayClose":117.46,"earningDate":1761580800000,"earningTime":"盘前"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NVS\",params:#limit:5,,,undefined,":[{"date":"2025-10-28","symbol":"NVS","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/09","expectedEps":2.26,"defaultRemindTime":1761638400000,"name":null,"time":"Pre-Market","dateTimestamp":1761624000000,"actualEps":null},{"market":"US","date":"2025-07-17","symbol":"NVS","fiscalQuarterEnding":"2025/06","expectedEps":2.38,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1752724800000,"reportTimeType":"pre","actualEps":2.42},{"market":"US","date":"2025-04-29","symbol":"NVS","fiscalQuarterEnding":"2025/03","expectedEps":2.12,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1745899200000,"reportTimeType":"pre","actualEps":2.28},{"date":"2025-03-12","symbol":"NVS","amount":3.86954,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-12","defaultRemindTime":1741786200000,"name":"诺华","lastCurrency":null,"lastExecuteDate":null,"recordDate":null,"payableDate":"2025-03-12","currency":"USD","dateTimestamp":1741752000000,"payDate":null},{"market":"US","date":"2025-01-31","symbol":"NVS","fiscalQuarterEnding":"2024/12","expectedEps":1.81,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738299600000,"reportTimeType":"pre","actualEps":1.98}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NVS\",market:\"US\",,,undefined,":[{"executeDate":"2016-02-24","recordDate":"2016-02-26","paymentDate":"2016-04-15","value":2.302755,"currency":"USD"},{"executeDate":"2019-03-04","recordDate":"2019-03-05","paymentDate":"2019-03-13","value":1.861996,"currency":"USD"},{"executeDate":"2020-03-03","recordDate":"2020-03-04","paymentDate":"2020-03-12","value":1.9776197,"currency":"USD"},{"executeDate":"2021-03-04","recordDate":"2021-03-05","paymentDate":"2021-03-15","value":2.1959459,"currency":"USD"},{"executeDate":"2022-03-08","recordDate":"2022-03-09","paymentDate":"2022-03-17","value":3.3574492,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NVS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0.5714,"sell":0.4286,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.5714,"analysts":7,"updateTime":1757822400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NVS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NVS","date":"2025-10-16","current":19.187046,"percent":0.540432,"low":7.087581,"twenty":11.017609,"median":18.04524,"eighty":26.178117,"high":33.848621,"avg":18.517917,"sd":7.44071,"marketCap":253934251455.19},"quantilePoints":[{"date":"2020-10-23","current":25.797382,"twenty":15.190989,"median":17.775785,"eighty":27.402807,"marketCap":185999119226.86},{"date":"2020-10-30","current":24.988388,"twenty":15.193883,"median":17.792728,"eighty":27.388696,"marketCap":177492523698.86},{"date":"2020-11-06","current":27.216027,"twenty":15.199589,"median":17.829937,"eighty":27.357723,"marketCap":193315439822.18},{"date":"2020-11-13","current":27.485895,"twenty":15.20954,"median":17.865475,"eighty":27.402807,"marketCap":195232311745.39},{"date":"2020-11-20","current":27.977491,"twenty":15.21419,"median":17.948734,"eighty":27.570986,"marketCap":198724117569.53},{"date":"2020-11-27","current":28.696184,"twenty":15.217792,"median":17.957315,"eighty":27.667977,"marketCap":203828990967.78},{"date":"2020-12-04","current":29.177337,"twenty":15.226366,"median":17.977434,"eighty":27.722608,"marketCap":207246629519.95},{"date":"2020-12-11","current":29.329405,"twenty":15.231613,"median":17.986357,"eighty":27.833026,"marketCap":208326758462.39},{"date":"2020-12-18","current":29.122537,"twenty":15.23366,"median":17.997105,"eighty":27.894825,"marketCap":206857381598.42},{"date":"2020-12-24","current":28.223441,"twenty":15.238838,"median":18.012439,"eighty":27.939463,"marketCap":200471097283.05},{"date":"2020-12-31","current":30.275456,"twenty":15.242355,"median":18.038048,"eighty":27.982482,"marketCap":215046563030.23},{"date":"2021-01-08","current":30.050051,"twenty":15.243996,"median":18.077533,"eighty":28.022419,"marketCap":213445512050.29},{"date":"2021-01-15","current":30.69708,"twenty":15.252301,"median":18.087632,"eighty":28.087076,"marketCap":218041359312.66},{"date":"2021-01-22","current":31.075017,"twenty":15.257047,"median":18.107937,"eighty":28.154132,"marketCap":220725844580.34},{"date":"2021-01-29","current":25.302982,"twenty":15.267282,"median":18.143206,"eighty":28.154132,"marketCap":204245667129.31},{"date":"2021-02-05","current":25.307678,"twenty":15.27441,"median":18.16572,"eighty":28.138918,"marketCap":204283575482.98},{"date":"2021-02-12","current":25.723524,"twenty":15.27628,"median":18.200034,"eighty":28.125839,"marketCap":207640289409.26},{"date":"2021-02-19","current":24.769133,"twenty":15.278711,"median":18.210204,"eighty":28.104835,"marketCap":199936445479.85},{"date":"2021-02-26","current":24.064713,"twenty":15.284399,"median":18.226261,"eighty":28.073741,"marketCap":194250364295.15},{"date":"2021-03-05","current":23.084461,"twenty":15.288901,"median":18.233974,"eighty":28.064113,"marketCap":186337768880.54},{"date":"2021-03-12","current":23.435071,"twenty":15.291775,"median":18.240532,"eighty":28.047441,"marketCap":189167893568.67},{"date":"2021-03-19","current":24.013766,"twenty":15.297229,"median":18.250058,"eighty":28.025738,"marketCap":193839113911.88},{"date":"2021-03-26","current":24.361283,"twenty":15.300148,"median":18.274818,"eighty":28.019013,"marketCap":196644272477.68},{"date":"2021-04-01","current":24.108173,"twenty":15.308128,"median":18.305737,"eighty":28.011747,"marketCap":194601172227.48},{"date":"2021-04-09","current":24.426603,"twenty":15.336914,"median":18.352215,"eighty":27.991619,"marketCap":197171541159.64},{"date":"2021-04-16","current":24.594705,"twenty":15.34149,"median":18.380221,"eighty":27.984722,"marketCap":198528460498.63},{"date":"2021-04-23","current":24.625032,"twenty":15.343269,"median":18.411754,"eighty":27.980886,"marketCap":198773259403.94},{"date":"2021-04-30","current":24.094521,"twenty":15.343969,"median":18.498755,"eighty":27.972917,"marketCap":191671912423.89},{"date":"2021-05-07","current":24.8617,"twenty":15.348946,"median":18.532645,"eighty":27.95159,"marketCap":197774820664.93},{"date":"2021-05-14","current":25.153836,"twenty":15.363808,"median":18.565357,"eighty":27.935232,"marketCap":200098770040.64},{"date":"2021-05-21","current":24.924084,"twenty":15.38257,"median":18.594345,"eighty":27.9145,"marketCap":198271089998.22},{"date":"2021-05-28","current":24.965271,"twenty":15.386047,"median":18.628586,"eighty":27.898767,"marketCap":198598732228.7},{"date":"2021-06-04","current":25.428717,"twenty":15.396316,"median":18.694716,"eighty":27.896766,"marketCap":202285445340.91},{"date":"2021-06-11","current":26.151461,"twenty":15.42367,"median":18.776218,"eighty":27.887062,"marketCap":208034875736.78},{"date":"2021-06-18","current":26.227743,"twenty":15.426334,"median":18.837947,"eighty":27.88023,"marketCap":208641694627},{"date":"2021-06-25","current":26.052263,"twenty":15.431826,"median":18.905909,"eighty":27.874868,"marketCap":207245745997.25},{"date":"2021-07-02","current":25.85105,"twenty":15.440199,"median":18.948871,"eighty":27.8383,"marketCap":205645103265.31},{"date":"2021-07-09","current":26.180675,"twenty":15.452123,"median":19.994076,"eighty":27.817206,"marketCap":208267270363.9},{"date":"2021-07-16","current":25.922565,"twenty":15.45839,"median":21.297567,"eighty":27.783193,"marketCap":206214009499.37},{"date":"2021-07-23","current":22.872298,"twenty":15.460519,"median":21.410694,"eighty":27.739049,"marketCap":205484727078.08},{"date":"2021-07-30","current":23.045934,"twenty":15.461717,"median":21.438592,"eighty":27.726383,"marketCap":207044671996.42},{"date":"2021-08-06","current":22.739522,"twenty":15.46988,"median":21.573064,"eighty":27.713849,"marketCap":204291865840.83},{"date":"2021-08-13","current":23.359628,"twenty":15.503564,"median":21.698856,"eighty":27.702531,"marketCap":209862894026.22},{"date":"2021-08-20","current":23.181179,"twenty":15.520325,"median":21.783237,"eighty":27.699801,"marketCap":208259712288.12},{"date":"2021-08-27","current":22.984623,"twenty":15.530062,"median":21.84709,"eighty":27.677778,"marketCap":206493850543.31},{"date":"2021-09-03","current":22.718035,"twenty":15.538322,"median":21.869287,"eighty":27.654974,"marketCap":204098826165.09},{"date":"2021-09-10","current":21.345254,"twenty":15.550583,"median":21.869287,"eighty":27.626214,"marketCap":191765758544.03},{"date":"2021-09-17","current":20.712438,"twenty":15.559277,"median":21.84709,"eighty":27.608358,"marketCap":186080540393.19},{"date":"2021-09-24","current":20.705728,"twenty":15.579952,"median":21.783237,"eighty":27.552824,"marketCap":186020268740.41},{"date":"2021-10-01","current":20.345304,"twenty":15.600577,"median":21.698856,"eighty":27.50635,"marketCap":182782211476.64},{"date":"2021-10-08","current":20.562654,"twenty":15.609566,"median":21.649563,"eighty":27.491371,"marketCap":184734878306.34},{"date":"2021-10-15","current":20.740241,"twenty":15.618942,"median":21.463043,"eighty":27.437499,"marketCap":186330331047.78},{"date":"2021-10-22","current":21.058392,"twenty":15.627389,"median":21.428036,"eighty":27.401594,"marketCap":189188586652.7},{"date":"2021-10-29","current":18.817338,"twenty":15.635032,"median":21.347439,"eighty":27.383461,"marketCap":184541630310.6},{"date":"2021-11-05","current":19.018891,"twenty":15.647289,"median":21.317885,"eighty":27.350089,"marketCap":186518259165.92},{"date":"2021-11-12","current":18.891167,"twenty":15.654532,"median":21.179825,"eighty":27.307652,"marketCap":185265673842.84},{"date":"2021-11-19","current":18.728326,"twenty":15.663321,"median":21.048046,"eighty":27.254761,"marketCap":183668699163.22},{"date":"2021-11-26","current":18.466622,"twenty":15.669452,"median":21.012114,"eighty":27.229251,"marketCap":181102155276.87},{"date":"2021-12-03","current":18.258168,"twenty":15.672299,"median":20.862779,"eighty":27.221869,"marketCap":179057860494.36},{"date":"2021-12-10","current":18.5005,"twenty":15.679373,"median":20.754728,"eighty":27.20819,"marketCap":181434401677.24},{"date":"2021-12-17","current":19.741364,"twenty":15.68813,"median":20.712438,"eighty":27.181553,"marketCap":193603556286.26},{"date":"2021-12-23","current":19.848527,"twenty":15.692775,"median":20.705728,"eighty":27.155854,"marketCap":194654498880},{"date":"2021-12-31","current":20.088424,"twenty":15.701331,"median":20.618532,"eighty":27.138533,"marketCap":197007170988.69},{"date":"2022-01-07","current":20.258584,"twenty":15.705623,"median":20.60602,"eighty":27.121927,"marketCap":198675935418.57},{"date":"2022-01-14","current":20.570686,"twenty":15.723796,"median":20.589637,"eighty":27.105451,"marketCap":201736710825.32},{"date":"2022-01-21","current":19.970714,"twenty":15.736051,"median":20.56667,"eighty":27.061491,"marketCap":195852789238.19},{"date":"2022-01-28","current":19.465055,"twenty":15.746378,"median":20.545058,"eighty":27.059181,"marketCap":190893794335.26},{"date":"2022-02-04","current":8.029227,"twenty":15.720732,"median":20.461012,"eighty":27.056778,"marketCap":192870073011.45},{"date":"2022-02-11","current":8.018981,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":192623938080.47},{"date":"2022-02-18","current":8.065272,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":193735890248.88},{"date":"2022-02-25","current":8.114918,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":194928434328.79},{"date":"2022-03-04","current":7.836403,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":188238254501.41},{"date":"2022-03-11","current":7.721781,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":185484909723.96},{"date":"2022-03-18","current":8.057829,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":193557099512.19},{"date":"2022-03-25","current":8.071441,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":193884091322.71},{"date":"2022-04-01","current":8.094547,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":194439100004.32},{"date":"2022-04-08","current":8.638654,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":207509117437.99},{"date":"2022-04-14","current":8.640519,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":207553893767.01},{"date":"2022-04-22","current":8.353937,"twenty":15.689822,"median":20.425342,"eighty":27.053184,"marketCap":200669919872.67},{"date":"2022-04-29","current":8.131471,"twenty":15.665963,"median":20.330649,"eighty":27.053184,"marketCap":196651481774.28},{"date":"2022-05-06","current":7.881676,"twenty":15.621187,"median":20.256294,"eighty":27.03613,"marketCap":190610438695.01},{"date":"2022-05-13","current":7.895122,"twenty":15.554139,"median":20.050708,"eighty":26.799658,"marketCap":190935630327.25},{"date":"2022-05-20","current":7.981506,"twenty":15.46988,"median":19.939865,"eighty":26.712067,"marketCap":193024747095},{"date":"2022-05-27","current":8.181613,"twenty":15.438524,"median":19.636273,"eighty":26.626409,"marketCap":197864120623.02},{"date":"2022-06-03","current":8.00738,"twenty":15.393749,"median":19.478952,"eighty":26.562818,"marketCap":193650479646.81},{"date":"2022-06-10","current":7.624373,"twenty":15.34334,"median":19.163283,"eighty":26.481397,"marketCap":184387844631.82},{"date":"2022-06-17","current":7.304054,"twenty":15.298712,"median":19.077284,"eighty":26.418719,"marketCap":176641242394.35},{"date":"2022-06-24","current":7.582309,"twenty":15.27964,"median":18.986834,"eighty":26.364561,"marketCap":183370574720.06},{"date":"2022-07-01","current":7.493877,"twenty":15.250273,"median":18.900841,"eighty":26.314464,"marketCap":181231913048.72},{"date":"2022-07-08","current":7.606086,"twenty":15.23199,"median":18.869162,"eighty":26.291679,"marketCap":183945576164.31},{"date":"2022-07-15","current":7.58856,"twenty":15.202136,"median":18.806098,"eighty":26.232109,"marketCap":183521723409.93},{"date":"2022-07-22","current":8.19561,"twenty":15.18337,"median":18.71718,"eighty":26.166494,"marketCap":188351517085.2},{"date":"2022-07-29","current":8.158045,"twenty":15.157076,"median":18.647438,"eighty":26.132159,"marketCap":187488206041.27},{"date":"2022-08-05","current":8.078369,"twenty":15.110436,"median":18.578085,"eighty":26.065871,"marketCap":185657067852.22},{"date":"2022-08-12","current":8.066066,"twenty":15.073457,"median":18.515669,"eighty":25.940642,"marketCap":185374335649.61},{"date":"2022-08-19","current":8.123102,"twenty":15.02629,"median":18.4837,"eighty":25.886111,"marketCap":186685117272.05},{"date":"2022-08-26","current":7.921009,"twenty":14.971809,"median":18.427077,"eighty":25.833627,"marketCap":182040613492.93},{"date":"2022-09-02","current":7.69931,"twenty":14.889831,"median":18.390521,"eighty":25.781076,"marketCap":176945538997.44},{"date":"2022-09-09","current":7.839444,"twenty":14.847478,"median":18.352215,"eighty":25.737059,"marketCap":180166100535.63},{"date":"2022-09-16","current":7.639838,"twenty":14.800639,"median":18.279395,"eighty":25.69413,"marketCap":175578771828.6},{"date":"2022-09-23","current":7.200687,"twenty":14.715721,"median":18.250058,"eighty":25.606633,"marketCap":165486184420.18},{"date":"2022-09-30","current":7.309364,"twenty":14.666961,"median":18.233974,"eighty":25.536644,"marketCap":167983801405.08},{"date":"2022-10-07","current":7.233971,"twenty":14.612953,"median":18.210204,"eighty":25.43593,"marketCap":166251109031.05},{"date":"2022-10-14","current":7.191933,"twenty":14.497159,"median":18.168977,"eighty":25.32345,"marketCap":165284995916.46},{"date":"2022-10-21","current":7.25195,"twenty":14.457826,"median":18.113862,"eighty":25.286138,"marketCap":166664300685.15},{"date":"2022-10-28","current":7.929368,"twenty":14.315805,"median":18.077533,"eighty":25.233079,"marketCap":172836429210.02},{"date":"2022-11-04","current":8.027551,"twenty":14.283277,"median":18.007982,"eighty":25.152421,"marketCap":174976531233.09},{"date":"2022-11-11","current":8.242312,"twenty":14.244857,"median":17.98094,"eighty":25.087357,"marketCap":179657664851.58},{"date":"2022-11-18","current":8.457603,"twenty":14.191615,"median":17.955359,"eighty":24.985599,"marketCap":184350366168.97},{"date":"2022-11-25","current":8.657467,"twenty":14.143838,"median":17.845766,"eighty":24.944555,"marketCap":188706817286.19},{"date":"2022-12-02","current":8.838391,"twenty":14.078613,"median":17.783631,"eighty":24.901055,"marketCap":192650402692.03},{"date":"2022-12-09","current":9.046654,"twenty":14.034813,"median":17.713631,"eighty":24.828177,"marketCap":197189931786.84},{"date":"2022-12-16","current":8.906442,"twenty":14.013992,"median":17.636168,"eighty":24.769512,"marketCap":194133722263.41},{"date":"2022-12-23","current":8.960744,"twenty":13.971607,"median":17.554825,"eighty":24.727245,"marketCap":195317323645.23},{"date":"2022-12-30","current":8.920871,"twenty":13.914951,"median":17.505765,"eighty":24.703969,"marketCap":194448241062.22},{"date":"2023-01-06","current":9.093242,"twenty":13.856188,"median":17.48301,"eighty":24.625204,"marketCap":198205406557.8},{"date":"2023-01-13","current":9.002411,"twenty":13.821776,"median":17.460761,"eighty":24.583673,"marketCap":196225557627.91},{"date":"2023-01-20","current":9.051584,"twenty":13.776842,"median":17.424808,"eighty":24.543498,"marketCap":197297374275.26},{"date":"2023-01-27","current":8.847624,"twenty":13.673815,"median":17.405208,"eighty":24.464769,"marketCap":192851676130.76},{"date":"2023-02-03","current":26.243556,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":182523930790.97},{"date":"2023-02-10","current":26.294961,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":182881448586.32},{"date":"2023-02-17","current":26.374513,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":183434736554.71},{"date":"2023-02-24","current":26.177477,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":182064354704.07},{"date":"2023-03-03","current":25.765519,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":179199184580.8},{"date":"2023-03-10","current":24.700467,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":171791749395.01},{"date":"2023-03-17","current":26.915798,"twenty":13.627087,"median":17.400788,"eighty":24.459661,"marketCap":187199370174.87},{"date":"2023-03-24","current":27.246033,"twenty":13.627087,"median":17.400788,"eighty":24.543498,"marketCap":189496154839.06},{"date":"2023-03-31","current":30.054098,"twenty":13.630004,"median":17.402998,"eighty":24.587255,"marketCap":209026250254.21},{"date":"2023-04-06","current":31.533443,"twenty":13.630004,"median":17.402998,"eighty":24.625118,"marketCap":219315097125.45},{"date":"2023-04-14","current":32.274976,"twenty":13.627087,"median":17.400788,"eighty":24.706379,"marketCap":224472453860.2},{"date":"2023-04-21","current":32.553317,"twenty":13.627087,"median":17.400788,"eighty":24.770643,"marketCap":226408322073.89},{"date":"2023-04-28","current":30.395591,"twenty":13.627087,"median":17.400788,"eighty":24.870311,"marketCap":213559421622.35},{"date":"2023-05-05","current":31.378954,"twenty":13.624171,"median":17.400508,"eighty":24.92381,"marketCap":220468531572.95},{"date":"2023-05-12","current":30.870482,"twenty":13.624171,"median":17.400508,"eighty":24.976352,"marketCap":216896002905.77},{"date":"2023-05-19","current":29.854888,"twenty":13.624171,"median":17.400508,"eighty":25.035144,"marketCap":209760441249.27},{"date":"2023-05-26","current":29.284412,"twenty":13.624171,"median":17.400508,"eighty":25.151225,"marketCap":205752279633.25},{"date":"2023-06-02","current":29.357697,"twenty":13.624171,"median":17.400508,"eighty":25.224214,"marketCap":206267176913.22},{"date":"2023-06-09","current":29.886389,"twenty":13.624171,"median":17.400508,"eighty":25.298929,"marketCap":209981771535.32},{"date":"2023-06-16","current":30.321305,"twenty":13.624171,"median":17.400508,"eighty":25.414052,"marketCap":213037486310.78},{"date":"2023-06-23","current":30.190139,"twenty":13.621254,"median":17.400228,"eighty":25.482171,"marketCap":212115917863.59},{"date":"2023-06-30","current":29.926736,"twenty":13.621254,"median":17.400228,"eighty":25.530882,"marketCap":210265246516.29},{"date":"2023-07-07","current":28.234527,"twenty":13.621254,"median":17.400228,"eighty":25.631737,"marketCap":198375788384.16},{"date":"2023-07-14","current":29.505671,"twenty":13.621254,"median":17.400228,"eighty":25.721137,"marketCap":207306851165.12},{"date":"2023-07-21","current":28.497251,"twenty":13.702614,"median":17.40584,"eighty":25.765158,"marketCap":217946975867.36},{"date":"2023-07-28","current":28.10544,"twenty":13.702614,"median":17.431322,"eighty":25.810163,"marketCap":214950408672.37},{"date":"2023-08-04","current":27.560871,"twenty":13.702614,"median":17.466898,"eighty":25.855767,"marketCap":210785535427.99},{"date":"2023-08-11","current":28.108004,"twenty":13.702614,"median":17.491087,"eighty":25.920889,"marketCap":214970019886.42},{"date":"2023-08-18","current":27.500668,"twenty":13.716822,"median":17.543114,"eighty":25.999939,"marketCap":210325106917.85},{"date":"2023-08-25","current":27.490856,"twenty":13.716822,"median":17.630823,"eighty":26.112124,"marketCap":210250065949.08},{"date":"2023-09-01","current":27.33691,"twenty":13.716822,"median":17.676024,"eighty":26.137251,"marketCap":209072687172.76},{"date":"2023-09-08","current":26.684355,"twenty":13.831992,"median":17.775785,"eighty":26.164037,"marketCap":204081948408.26},{"date":"2023-09-15","current":27.8918,"twenty":13.863753,"median":17.829937,"eighty":26.195299,"marketCap":213316484771.89},{"date":"2023-09-22","current":27.529162,"twenty":13.863753,"median":17.948734,"eighty":26.256036,"marketCap":210543032637.27},{"date":"2023-09-29","current":27.704599,"twenty":13.863753,"median":17.977965,"eighty":26.294822,"marketCap":211884773857.62},{"date":"2023-10-06","current":26.136777,"twenty":13.863753,"median":17.998187,"eighty":26.307358,"marketCap":199894070259.72},{"date":"2023-10-13","current":26.099935,"twenty":13.931808,"median":18.076116,"eighty":26.318536,"marketCap":199612304286.36},{"date":"2023-10-20","current":25.606741,"twenty":13.931808,"median":18.102011,"eighty":26.318536,"marketCap":195840357582.32},{"date":"2023-10-27","current":24.415836,"twenty":13.914417,"median":18.144394,"eighty":26.326723,"marketCap":191322491088.71},{"date":"2023-11-03","current":24.121849,"twenty":13.914417,"median":18.186711,"eighty":26.326723,"marketCap":189018809684.75},{"date":"2023-11-10","current":24.455041,"twenty":13.914417,"median":18.226261,"eighty":26.326723,"marketCap":191629701060.59},{"date":"2023-11-17","current":24.852995,"twenty":13.914417,"median":18.240532,"eighty":26.326723,"marketCap":194748066897.24},{"date":"2023-11-24","current":25.763747,"twenty":13.914417,"median":18.264257,"eighty":26.326723,"marketCap":201884721514.42},{"date":"2023-12-01","current":25.681448,"twenty":13.914417,"median":18.308684,"eighty":26.326723,"marketCap":201239827121.68},{"date":"2023-12-08","current":25.351528,"twenty":13.918256,"median":18.360699,"eighty":26.322856,"marketCap":198654572969.12},{"date":"2023-12-15","current":25.72582,"twenty":13.918256,"median":18.394754,"eighty":26.322856,"marketCap":201587524553.81},{"date":"2023-12-22","current":25.978676,"twenty":13.918256,"median":18.447118,"eighty":26.322856,"marketCap":203568905697.84},{"date":"2023-12-29","current":26.529514,"twenty":13.914417,"median":18.483927,"eighty":26.348002,"marketCap":207885278188.64},{"date":"2024-01-05","current":27.901829,"twenty":13.910577,"median":18.51381,"eighty":26.370883,"marketCap":218638738608.88},{"date":"2024-01-12","current":28.036514,"twenty":13.910577,"median":18.571472,"eighty":26.422243,"marketCap":219694129152.93},{"date":"2024-01-19","current":28.352927,"twenty":13.906738,"median":18.628586,"eighty":26.470944,"marketCap":222173534575.94},{"date":"2024-01-26","current":27.949174,"twenty":13.910577,"median":18.684776,"eighty":26.521392,"marketCap":219009721879.32},{"date":"2024-02-02","current":14.397684,"twenty":13.910577,"median":18.71718,"eighty":26.537684,"marketCap":213805607321.99},{"date":"2024-02-09","current":13.900537,"twenty":13.868427,"median":18.71718,"eighty":26.537684,"marketCap":206422982529.79},{"date":"2024-02-16","current":13.813113,"twenty":13.687988,"median":18.71718,"eighty":26.537684,"marketCap":205124721398.18},{"date":"2024-02-23","current":14.305017,"twenty":13.687988,"median":18.71718,"eighty":26.537684,"marketCap":212429491580.85},{"date":"2024-03-01","current":14.052638,"twenty":13.704706,"median":18.708576,"eighty":26.536229,"marketCap":208681673875.32},{"date":"2024-03-08","current":13.812509,"twenty":13.704706,"median":18.708576,"eighty":26.536229,"marketCap":205115751567.13},{"date":"2024-03-15","current":13.350493,"twenty":13.599085,"median":18.708576,"eighty":26.536229,"marketCap":198254813990.44},{"date":"2024-03-22","current":14.193287,"twenty":13.599085,"median":18.708576,"eighty":26.536229,"marketCap":210770303493.35},{"date":"2024-03-28","current":14.305417,"twenty":13.599085,"median":18.708576,"eighty":26.536229,"marketCap":212435439752.63},{"date":"2024-04-05","current":14.023817,"twenty":13.576499,"median":18.71718,"eighty":26.537684,"marketCap":208253683585.27},{"date":"2024-04-12","current":13.933033,"twenty":13.576499,"median":18.71718,"eighty":26.537684,"marketCap":206905536915.4},{"date":"2024-04-19","current":13.841097,"twenty":13.576499,"median":18.71718,"eighty":26.537684,"marketCap":205540289930.65},{"date":"2024-04-26","current":13.116641,"twenty":13.098986,"median":18.708576,"eighty":26.536229,"marketCap":199963177263.62},{"date":"2024-05-03","current":12.901312,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":196680491183.63},{"date":"2024-05-10","current":13.62556,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":207721668262.32},{"date":"2024-05-17","current":13.811142,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":210550870720.47},{"date":"2024-05-24","current":13.427426,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":204701108813.04},{"date":"2024-05-31","current":13.801388,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":210402159392.6},{"date":"2024-06-07","current":14.179941,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":216173203205.72},{"date":"2024-06-14","current":14.268027,"twenty":12.986611,"median":18.708576,"eighty":26.536229,"marketCap":217516057210.18},{"date":"2024-06-21","current":14.065609,"twenty":12.9792,"median":18.71718,"eighty":26.537684,"marketCap":214430202954.07},{"date":"2024-06-28","current":14.323938,"twenty":12.9792,"median":18.71718,"eighty":26.537684,"marketCap":218368442284.67},{"date":"2024-07-05","current":14.408073,"twenty":12.9792,"median":18.71718,"eighty":26.537684,"marketCap":219651075334.28},{"date":"2024-07-12","current":14.975492,"twenty":12.9792,"median":18.71718,"eighty":26.537684,"marketCap":228301366570.5},{"date":"2024-07-19","current":13.268905,"twenty":12.9792,"median":18.699973,"eighty":26.537684,"marketCap":214624531043.21},{"date":"2024-07-26","current":13.816724,"twenty":12.9792,"median":18.647438,"eighty":26.537684,"marketCap":223485507190.68},{"date":"2024-08-02","current":14.090751,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":227917912437.95},{"date":"2024-08-09","current":13.993585,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":226346245790.31},{"date":"2024-08-16","current":14.328569,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":231764593445.89},{"date":"2024-08-23","current":14.823692,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":239773222258.92},{"date":"2024-08-30","current":15.052963,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":243481670102.69},{"date":"2024-09-06","current":14.666925,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":237237514593.86},{"date":"2024-09-13","current":14.492452,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":234415404725.28},{"date":"2024-09-20","current":14.554631,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":235421158822.98},{"date":"2024-09-27","current":14.550661,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":235356938553.67},{"date":"2024-10-04","current":14.222187,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":230043877046.97},{"date":"2024-10-11","current":14.520941,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":234876221387.16},{"date":"2024-10-18","current":14.601536,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":236179853851.57},{"date":"2024-10-25","current":14.25487,"twenty":12.9792,"median":18.630113,"eighty":26.537684,"marketCap":230572528460.12},{"date":"2024-11-01","current":12.467183,"twenty":12.48247,"median":18.630113,"eighty":26.537684,"marketCap":219459823948.45},{"date":"2024-11-08","current":12.062797,"twenty":12.124753,"median":18.630113,"eighty":26.537684,"marketCap":212341406668.12},{"date":"2024-11-15","current":11.7308,"twenty":11.840322,"median":18.630113,"eighty":26.537684,"marketCap":206497268589.51},{"date":"2024-11-22","current":11.890254,"twenty":11.704725,"median":18.630113,"eighty":26.537684,"marketCap":209304132283.23},{"date":"2024-11-29","current":12.013144,"twenty":11.704725,"median":18.630113,"eighty":26.537684,"marketCap":211467357651.39},{"date":"2024-12-06","current":11.627758,"twenty":11.645281,"median":18.630113,"eighty":26.537684,"marketCap":204683425855.25},{"date":"2024-12-13","current":11.155398,"twenty":11.272574,"median":18.630113,"eighty":26.537684,"marketCap":196368468258.14},{"date":"2024-12-20","current":11.016834,"twenty":11.072841,"median":18.630113,"eighty":26.537684,"marketCap":193929327376.35},{"date":"2024-12-27","current":11.195581,"twenty":11.031387,"median":18.630113,"eighty":26.537684,"marketCap":197075816359.8},{"date":"2025-01-03","current":11.113975,"twenty":11.029071,"median":18.630113,"eighty":26.537684,"marketCap":195639289814.34},{"date":"2025-01-10","current":11.275607,"twenty":11.023437,"median":18.638776,"eighty":26.539138,"marketCap":198484509661.91},{"date":"2025-01-17","current":11.097752,"twenty":11.023437,"median":18.638776,"eighty":26.539138,"marketCap":195353731331.02},{"date":"2025-01-24","current":11.330187,"twenty":11.023437,"median":18.638776,"eighty":26.539138,"marketCap":199445294080.33},{"date":"2025-01-31","current":17.385101,"twenty":11.023437,"median":18.638776,"eighty":26.539138,"marketCap":207595485091.71},{"date":"2025-02-07","current":17.614207,"twenty":11.023437,"median":18.638776,"eighty":26.539138,"marketCap":210331245815.87},{"date":"2025-02-14","current":17.568499,"twenty":11.023437,"median":18.492327,"eighty":26.539138,"marketCap":209785454321.8},{"date":"2025-02-21","current":18.05046,"twenty":11.023437,"median":18.437098,"eighty":26.539138,"marketCap":215540543803.02},{"date":"2025-02-28","current":17.913341,"twenty":11.023437,"median":18.437098,"eighty":26.539138,"marketCap":213903205942.89},{"date":"2025-03-07","current":19.003167,"twenty":11.017803,"median":18.484154,"eighty":26.540593,"marketCap":226916823474.23},{"date":"2025-03-14","current":18.012835,"twenty":11.017803,"median":18.5005,"eighty":26.540593,"marketCap":215091268671.02},{"date":"2025-03-21","current":17.849274,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":213138179550.63},{"date":"2025-03-28","current":17.788275,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":212409793703.96},{"date":"2025-04-04","current":17.082813,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":203985871294.58},{"date":"2025-04-11","current":16.768387,"twenty":11.023437,"median":18.538324,"eighty":26.539138,"marketCap":200231305726.4},{"date":"2025-04-17","current":17.580919,"twenty":11.023437,"median":18.538324,"eighty":26.539138,"marketCap":209933754161.38},{"date":"2025-04-25","current":17.730023,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":211714201787.97},{"date":"2025-05-02","current":17.380553,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":223496525732.55},{"date":"2025-05-09","current":16.696941,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":214705962988.5},{"date":"2025-05-16","current":16.597916,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":213432604432.69},{"date":"2025-05-23","current":17.060987,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":219387243488.65},{"date":"2025-05-30","current":17.399171,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":223735936665.37},{"date":"2025-06-06","current":18.03736,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":231942405204.56},{"date":"2025-06-13","current":18.199363,"twenty":11.017803,"median":18.560503,"eighty":26.540593,"marketCap":234025607559.44},{"date":"2025-06-20","current":17.650046,"twenty":11.017609,"median":18.580101,"eighty":26.542981,"marketCap":226961939753.89},{"date":"2025-06-27","current":18.306798,"twenty":11.017609,"median":18.580101,"eighty":26.542981,"marketCap":235407114231.28},{"date":"2025-07-03","current":18.551811,"twenty":11.017609,"median":18.637113,"eighty":26.542981,"marketCap":238557726687.71},{"date":"2025-07-11","current":18.390521,"twenty":11.017609,"median":18.669713,"eighty":26.542981,"marketCap":236483711168.25},{"date":"2025-07-18","current":16.259664,"twenty":11.017609,"median":18.669713,"eighty":26.542981,"marketCap":222009457365.11},{"date":"2025-07-25","current":16.563324,"twenty":11.017609,"median":18.637113,"eighty":26.542981,"marketCap":226155626091.5},{"date":"2025-08-01","current":16.440167,"twenty":11.017609,"median":18.51407,"eighty":26.542981,"marketCap":224474032398.53},{"date":"2025-08-08","current":16.510159,"twenty":11.017609,"median":18.467955,"eighty":26.542981,"marketCap":225429723871.84},{"date":"2025-08-15","current":17.461548,"twenty":11.017609,"median":18.425945,"eighty":26.542981,"marketCap":238419967163.07},{"date":"2025-08-22","current":17.895944,"twenty":11.017609,"median":18.375177,"eighty":26.542981,"marketCap":244351227512.78},{"date":"2025-08-29","current":17.881488,"twenty":11.017609,"median":18.270567,"eighty":26.537163,"marketCap":244153835649.81},{"date":"2025-09-05","current":18.285354,"twenty":11.017415,"median":18.229362,"eighty":26.479478,"marketCap":249668226793.84},{"date":"2025-09-12","current":17.610165,"twenty":11.017609,"median":18.178951,"eighty":26.409491,"marketCap":240449195357.11},{"date":"2025-09-19","current":17.504643,"twenty":11.017609,"median":18.112179,"eighty":26.343162,"marketCap":239008405447.73},{"date":"2025-09-26","current":17.430562,"twenty":11.017609,"median":18.052715,"eighty":26.273346,"marketCap":237996893599.29},{"date":"2025-10-03","current":18.668277,"twenty":11.017609,"median":18.04524,"eighty":26.231511,"marketCap":254896663088.94},{"date":"2025-10-10","current":18.461585,"twenty":11.017609,"median":18.04524,"eighty":26.194217,"marketCap":252074474123.51},{"date":"2025-10-16","current":18.597792,"twenty":11.017609,"median":18.04524,"eighty":26.178117,"marketCap":253934251455.19}],"updateTime":1760760710923},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NVS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2576758066","title":"Nyse Order Imbalance  90059.0 Shares on Sell Side","url":"https://stock-news.laohu8.com/highlight/detail?id=2576758066","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576758066?lang=en_us&edition=fundamental","pubTime":"2025-10-18 03:50","pubTimestamp":1760730602,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251017:nAQN2L3QWH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0208291251.USD","IE00BJT1NW94.SGD","NVS","BK4007","IE00B2B36J28.USD","LU0070302665.USD","LU0320765489.SGD","IE0002141913.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4588","BK4578","IE00BJJMRZ35.SGD","BK4532","BK4585","IE00B4R5TH58.HKD","LU0211331839.USD"],"gpt_icon":0},{"id":"2576058366","title":"Novartis Says 5-Year Kisqali Data Cut Early Breast Cancer Recurrence by 28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576058366","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576058366?lang=en_us&edition=fundamental","pubTime":"2025-10-17 20:52","pubTimestamp":1760705551,"startTime":"0","endTime":"0","summary":"Novartis  said Friday that five-year results from the phase 3 Natalee study show Kisqali plus endocrine therapy reduced the risk of recurrence by 28% in early HR-positive or HER2-negative breast cancer versus endocrine therapy alone.The combined regimen delivered an 85.5% invasive disease-free survival rate at five years versus 81% for endocrine therapy alone, the company said.Benefit was seen across key subgroups, including patients without lymph-node involvement, Novartis said.Kisqali also showed a 29% reduction in the risk of distant recurrence and a favorable trend in overall survival, though survival data remain immature, the company added.Additionally, the company also said roughly two years after patients finished the three-year Kisqali course, no new safety issues were observed.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0208291251.USD","BK4532","LU0320765489.SGD","BK4585","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","BK4578","IE0002141913.USD","IE0009355771.USD","IE00B4R5TH58.HKD","LU0070302665.USD","NVS","BK4007","BK4588","LU0211331839.USD"],"gpt_icon":0},{"id":"2576703005","title":"Novartis Says European Regulator Backs Expanded Use of Blood Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2576703005","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576703005?lang=en_us&edition=fundamental","pubTime":"2025-10-17 20:46","pubTimestamp":1760705185,"startTime":"0","endTime":"0","summary":"Novartis  said Friday that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued a positive opinion on Scemblix for the treatment of adult patients with Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase across all lines of treatment.The drugmaker said the recommendation was based on results from a phase III trial that demonstrated superior major molecular response rates, fewer dose reductions, and half the rate of treatment discontinuation due to side effects compared with the investigators' choice of tyrosine kinase inhibitor treatment in patients.The European Commission is expected to make a final decision on the CHMP recommendation within two months. If approved, Scemblix will be indicated for both newly diagnosed and previously treated adults, expanding access to four times as many patients in Europe, Novartis said.Scemblix is already approved for earlier-line use in over 20 countries, including the US, Japan, an","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","LU0320765489.SGD","IE0009355771.USD","BK4532","IE00BJJMRZ35.SGD","BK4007","LU0070302665.USD","BK4578","IE00B4R5TH58.HKD","NVS","BK4588","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","LU0211331839.USD","LU0208291251.USD","IE00BJT1NW94.SGD","IE0002141913.USD"],"gpt_icon":0},{"id":"2576031359","title":"Novartis Scemblix receives positive CHMP opinion for Scemblix","url":"https://stock-news.laohu8.com/highlight/detail?id=2576031359","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576031359?lang=en_us&edition=fundamental","pubTime":"2025-10-17 18:55","pubTimestamp":1760698518,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced that the Committee for Medicinal Products for Human Use, CHMP, of the European Medicines Agency, EMA, has adopted a positi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-scemblix-receives-positive-chmp-opinion-for-scemblix-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-scemblix-receives-positive-chmp-opinion-for-scemblix-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00B2B36J28.USD","CHMP","IE0009355771.USD","IE0002141913.USD","BK4578","BK4087","LU0070302665.USD","BK4532","LU0211331839.USD","BK4585","LU0320765489.SGD","IE00B4R5TH58.HKD","BK4007","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0208291251.USD","IE00BJT1NW94.SGD","NVS","BK4588"],"gpt_icon":0},{"id":"2576721761","title":"Small-Cap Biotech Climb Bio's Lead Drug Candidate Has Larger Long-Term Opportunity","url":"https://stock-news.laohu8.com/highlight/detail?id=2576721761","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2576721761?lang=en_us&edition=fundamental","pubTime":"2025-10-17 01:40","pubTimestamp":1760636400,"startTime":"0","endTime":"0","summary":"William Blair assigns Climb Bio an Outperform rating, projecting peak sales of $1.9 billion and long-term growth for its therapy pipeline.","market":"nz","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/10/16/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=260","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/10/16/Genetic-Research-And-Biotech-Science-Con.jpeg?optimize=medium&dpr=2&auto=webp&width=260"],"rights":{"source":"benzinga_hot_news","url":"https://www.benzinga.com/news/25/10/48258939/small-cap-biotech-climb-bios-lead-drug-candidate-has-larger-long-term-opportunity","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/25/10/48258939/small-cap-biotech-climb-bios-lead-drug-candidate-has-larger-long-term-opportunity","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_hot_news","symbols":["AMGN","LU0234570918.USD","BIIB","IE00B19Z9Z06.USD","LU0109394709.USD","TSYW.SI","LU0868494617.USD","USAW.SI","LU0058720904.USD","LU0211331839.USD","MNQmain","IE00BJJMRZ35.SGD","TGTX","BK4539","LU0122379950.USD","LU1057294990.SGD","QID",".IXIC","IE00BFTCPJ56.SGD","CLYM","IE00B19Z9P08.USD","NPV","LU0208291251.USD","BK4581","LU1061106388.HKD","NQmain","PSQ","SQQQ","BK4533","IE00B4R5TH58.HKD","NVS","CTA","IE0009355771.USD","SG9999001440.SGD","LU1023059063.AUD","BK4588","QLD","USJW.SI","LU2089984988.USD","TQQQ","IE00B2B36J28.USD","BK4007","NVIW.SI","LU2242646821.SGD","BK4534","IE00BJT1NW94.SGD","LU1571399168.USD","IE0002141913.USD","BK4532"],"gpt_icon":1},{"id":"2575881748","title":"Novartis' Phase 3 Study of Fabhalta in IgA Nephropathy Meets Primary Endpoint","url":"https://stock-news.laohu8.com/highlight/detail?id=2575881748","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575881748?lang=en_us&edition=fundamental","pubTime":"2025-10-16 19:16","pubTimestamp":1760613415,"startTime":"0","endTime":"0","summary":"Novartis  said Thursday that its phase 3 study of Fabhalta in adults with IgA nephropathy kidney disease, or IgAn, met its primary endpoint.The achieved primary endpoint is a \"statistically significant\" improvement in estimated glomerular filtration rate, or eGFR, slope compared with placebo over two years, the company said, noting that eGFR is key marker of kidney function.Another primary endpoint is proteinuria reduction at nine months as measured by UPCR, according to Novartis.Novartis also said Fabhalta was well tolerated during the phase 3 trial, with a safety profile consistent with previously reported data.The company said it plans to use the trial's data to support submissions for Fabhalta in 2026.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BFTCPJ56.SGD","IE0002141913.USD","BK4532","LU0208291251.USD","IE00B2B36J28.USD","BK4007","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","LU0070302665.USD","NVS","BK4578","LU0320765489.SGD","LU0211331839.USD","IE0009355771.USD","BK4588","BK4585"],"gpt_icon":0},{"id":"2575175217","title":"Novartis announces Phase III study of Fabhalta showed superiority to placebo","url":"https://stock-news.laohu8.com/highlight/detail?id=2575175217","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575175217?lang=en_us&edition=fundamental","pubTime":"2025-10-16 18:36","pubTimestamp":1760610966,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced positive final results from APPLAUSE-IgAN, a Phase III study evaluating Fabhalta in adults living with IgA nephropathy, Ig...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-phase-iii-study-of-fabhalta-showed-superiority-to-placebo-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-phase-iii-study-of-fabhalta-showed-superiority-to-placebo-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0320765489.SGD","IE00BFTCPJ56.SGD","BK4585","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","LU0211331839.USD","NVS","BK4588","BK4007","IE00B2B36J28.USD","IE0002141913.USD","BK4578","BK4532","LU0070302665.USD","IE00BJJMRZ35.SGD","BK4134","IE0009355771.USD","LU0208291251.USD","III"],"gpt_icon":0},{"id":"2575204467","title":"Novartis Growth Should Normalize After Successful Turnaround -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2575204467","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575204467?lang=en_us&edition=fundamental","pubTime":"2025-10-15 16:59","pubTimestamp":1760518740,"startTime":"0","endTime":"0","summary":"0859 GMT - Novartis completed a successful transformation and now outperforms its peers, but growth is set to normalize, Vontobel's Stefan Schneider writes. The Swiss pharma group's valuation now reflects its recent growth, though this happened more slowly than expected given nine straight quarters of Novartis beating and raising guidance, the analyst says. This is unlikely to be repeated when the company releases third-quarter results later this month, its first report since heart failure drug Entresto lost patent exclusivity, the analysts add. Novartis seems poised to deliver slower growth going forward, the analyst says. Vontobel cuts its recommendation on Novartis stock to hold from buy and keeps its target price of 112 Swiss francs. Shares fall 1.1% to 102.92 francs. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","IE0002141913.USD","IE00BJJMRZ35.SGD","BK4578","IE00B4R5TH58.HKD","BK4585","BK4532","IE0009355771.USD","LU0070302665.USD","BK4588","LU0211331839.USD","IE00B2B36J28.USD","NVS","LU0208291251.USD","LU0320765489.SGD","BK4007","IE00BJT1NW94.SGD"],"gpt_icon":0},{"id":"2575405074","title":"Novartis Growth Likely to Stall on Cosentyx Sales Slide -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2575405074","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575405074?lang=en_us&edition=fundamental","pubTime":"2025-10-13 20:11","pubTimestamp":1760357460,"startTime":"0","endTime":"0","summary":"1206 GMT - Novartis's earnings growth will stall in 2026 due to larger-than-expected losses from slowing sales of its Cosentyx autoimmune treatment, Intron Health analysts write. Cosentyx U.S. sales are likely to drop 17% mainly due to increased competition and lower prices and compared with consensus forecasts for a 10% rise, the analysts say. The decrease could cut Novartis's EBIT by about 5%, they add. Together with the Swiss pharma group's Entresto heart-failure drug loss of patent exclusivity, this will likely lead to flat earnings per share next year, the analysts write. Moreover, Novartis's long-term revenue growth remains weak and lags that of other major European drugmakers, the analysts add. Intron Health cuts its recommendation on Novartis's stock to hold from buy. Shares fall 0.4% Monday and are up 18% year to date. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0208291251.USD","IE00BJJMRZ35.SGD","BK4007","IE0009355771.USD","NVS","LU0211331839.USD","BK4588","IE00BJT1NW94.SGD","BK4585","IE0002141913.USD","LU0320765489.SGD","BK4532","BK4578","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU0070302665.USD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"1179003778","title":"Pharma Shares Rally. Eli Lilly Up Nearly 3%; Novo, Johnson & Johnson Up Around 2%; Sanofi, Pfizer, Astrazeneca Up Over 1%","url":"https://stock-news.laohu8.com/highlight/detail?id=1179003778","media":"Tiger Newspress","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1179003778?lang=en_us&edition=fundamental","pubTime":"2025-10-03 22:49","pubTimestamp":1759502993,"startTime":"0","endTime":"0","summary":"Pharma shares rallied on Friday. Eli Lilly up nearly 3%; Novo, Johnson & Johnson up around 2%; Sanofi, Pfizer, AstraZeneca up over 1%.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"4696633c589b47e403d3f9d9fe1681de","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFE","LLY","NVAX","NVO","JNJ","MRNA","MRK","NVS"],"gpt_icon":0},{"id":"2572350355","title":"Immatics Names Venkat Ramanan CFO","url":"https://stock-news.laohu8.com/highlight/detail?id=2572350355","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572350355?lang=en_us&edition=fundamental","pubTime":"2025-10-01 19:43","pubTimestamp":1759319014,"startTime":"0","endTime":"0","summary":"Immatics (IMTX) said Wednesday it has appointed Venkat Ramanan as its chief financial officer.Ramanan, who succeeds Arnd Christ, was previously the CFO of Anthos Therapeutics, which was acquired by Novartis (NVS) in April.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE0009355771.USD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE0002141913.USD","BK4007","IMTX","NVS","LU0208291251.USD","BK4585","IE00BJJMRZ35.SGD","LU0070302665.USD","BK4139","BK4578","BK4588","BK4532","LU0211331839.USD","IE00BJT1NW94.SGD","LU0320765489.SGD","IE00B4R5TH58.HKD"],"gpt_icon":0},{"id":"2572584482","title":"Novartis Receives FDA Approval for Skin Condition Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2572584482","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572584482?lang=en_us&edition=fundamental","pubTime":"2025-10-01 16:34","pubTimestamp":1759307677,"startTime":"0","endTime":"0","summary":"Novartis  said late Tuesday the US Food and Drug Administration has approved Rhapsido for adult patients with chronic spontaneous urticaria who remain symptomatic despite H1 antihistamine treatment.Chronic spontaneous urticaria is a skin condition characterized by the appearance of itchy hives and swelling.The company said the approval was based on the results of two phase 3 trials, where Rhapsido demonstrated \"superiority\" in change from baseline, compared with placebo, in itch, hives, and weekly urticaria activity at week 12.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4578","BK4007","IE00B4R5TH58.HKD","BK4532","IE00B2B36J28.USD","BK4588","LU0211331839.USD","IE0009355771.USD","NVS","IE0002141913.USD","LU0070302665.USD","IE00BJT1NW94.SGD","BK4585","IE00BFTCPJ56.SGD","LU0208291251.USD","IE00BJJMRZ35.SGD","LU0320765489.SGD"],"gpt_icon":0},{"id":"2572586539","title":"Novartis Bags First FDA Approval for Rhapsido, More Could Follow -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2572586539","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572586539?lang=en_us&edition=fundamental","pubTime":"2025-10-01 14:47","pubTimestamp":1759301220,"startTime":"0","endTime":"0","summary":"0646 GMT - Novartis's Rhapsido received approval from the U.S. Food and Drug Administration to treat hives, but the drug is also being evaluated in other conditions that could expand the company's immunology and neuroscience portfolios, Vontobel's Stefan Schneider says. Sales for Rhapsido--commercial name of the drug known until now as remibrutinib--in spontaneous hives, or urticaria, could hit $1.75 billion, according to Vontobel. The Swiss pharmaceutical company is also conducting trials for food allergy and other skin conditions that could expand its immunology portfolio, the analyst says in a research note. The drug is also being studied for multiple sclerosis and myasthenia, which could support growth in Novartis's neuroscience portfolio, he says. Line extensions are likely to make up a large chunk of Novartis's upcoming updates, Vontobel says. ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NVS","BK4007","BK4532","IE0009355771.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","BK4588","IE00BJT1NW94.SGD","BK4585","LU0208291251.USD","IE00B4R5TH58.HKD","BK4578","IE0002141913.USD","IE00B2B36J28.USD","LU0070302665.USD","LU0211331839.USD","LU0320765489.SGD"],"gpt_icon":0},{"id":"2572693377","title":"Novartis announces FDA approval of Rhapsido for treatment of CSU","url":"https://stock-news.laohu8.com/highlight/detail?id=2572693377","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2572693377?lang=en_us&edition=fundamental","pubTime":"2025-10-01 05:30","pubTimestamp":1759267830,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced that Rhapsido received U.S. FDA approval as an oral treatment for adult patients with chronic spontaneous urticaria who re...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-treatment-of-csu-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-announces-fda-approval-of-rhapsido-for-treatment-of-csu-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4578","BK4588","LU0320765489.SGD","IE0009355771.USD","LU0208291251.USD","IE00BFTCPJ56.SGD","BK4585","IE00BJT1NW94.SGD","BK4532","BK4007","IE00B4R5TH58.HKD","IE00B2B36J28.USD","LU0070302665.USD","LU0211331839.USD","NVS","IE00BJJMRZ35.SGD","IE0002141913.USD"],"gpt_icon":0},{"id":"2571351075","title":"Pharma's Direct-To-Patient Wave Hits Novartis Next","url":"https://stock-news.laohu8.com/highlight/detail?id=2571351075","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571351075?lang=en_us&edition=fundamental","pubTime":"2025-09-30 02:01","pubTimestamp":1759168860,"startTime":"0","endTime":"0","summary":"The Pharmaceutical Research and Manufacturers of America (PhRMA) outlined initiatives to bolster U.S. manufacturing, ease patient costs, and improve access to medicine.","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/09/29/Novartis.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/09/29/Novartis.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/news/health-care/25/09/47925052/pharmas-direct-to-patient-wave-hits-novartis-next","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/health-care/25/09/47925052/pharmas-direct-to-patient-wave-hits-novartis-next","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["BK4578","IE0009355771.USD","BK4585","IE00BFTCPJ56.SGD","LU0208291251.USD","BK4007","LU0070302665.USD","LU0211331839.USD","BK4532","NVS","LU0320765489.SGD","IE00B4R5TH58.HKD","IE00BJT1NW94.SGD","BK4588","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","DTP","IE0002141913.USD"],"gpt_icon":0},{"id":"2571333218","title":"Novartis to launch direct-to-patient platform for Cosentyx in U.S.","url":"https://stock-news.laohu8.com/highlight/detail?id=2571333218","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2571333218?lang=en_us&edition=fundamental","pubTime":"2025-09-29 20:20","pubTimestamp":1759148428,"startTime":"0","endTime":"0","summary":"Novartis (NVS) announced plans to launch a direct-to-patient platform in the U.S. which will come into effect on November 1, offering cash-paying p...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/novartis-to-launch-direct-to-patient-platform-for-cosentyx-in-u-s-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/novartis-to-launch-direct-to-patient-platform-for-cosentyx-in-u-s-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","BK4532","LU0208291251.USD","IE0009355771.USD","IE0002141913.USD","IE00BFTCPJ56.SGD","LU0320765489.SGD","BK4578","BK4585","IE00BJT1NW94.SGD","IE00B2B36J28.USD","LU0211331839.USD","IE00BJJMRZ35.SGD","BK4588","IE00B4R5TH58.HKD","NVS","LU0070302665.USD"],"gpt_icon":0},{"id":"2570838706","title":"European Equities Close Higher in Friday Trading; Eurozone Consumer Inflation Expectations Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2570838706","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570838706?lang=en_us&edition=fundamental","pubTime":"2025-09-27 00:10","pubTimestamp":1758903009,"startTime":"0","endTime":"0","summary":"European stock markets closed higher in Friday trading as the Stoxx Europe 600 was up 0.75%, Germany's DAX gained 0.84%, the FTSE 100 rose 0.77%, France's CAC increased 0.97% and the Swiss Market Inde","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0820561909.HKD","BK4554","LU0314106906.USD","LU2054465674.USD","TTE","LU1032955483.USD","BK4516","GOOG","LU0203201768.USD","LU1221951129.SGD","GOOGL","LU0130102774.USD","BK4602","XOM","LU0726765562.USD","BK4548","LU0353189680.USD","LU1629891620.HKD","NVS","BK4566","LU0823434583.USD","SGXZ31699556.SGD","LU1564329461.SGD","BK4538","BK4543","LU0203347892.USD","LU2111349929.HKD","LU2237443622.USD","META","LU1880398471.USD","LU2286300806.USD","E","LU0316494557.USD","LU2237443895.HKD","LU2462157665.USD","BK4587","USJW.SI","LU0289941410.SGD","FB","BK4550","LU0964807845.USD","LU2168563687.JPY","LU2471134952.CNY","IE00BZ1G4Q59.USD","LU1633808545.USD","LU2420271590.USD","LU2456880835.USD","IE00B775H168.HKD","LU1244550577.SGD","LU1244550494.USD"],"gpt_icon":1},{"id":"2570917885","title":"Amneal Pharmaceuticals Files Biologics License Application for Xolair Biosimilar","url":"https://stock-news.laohu8.com/highlight/detail?id=2570917885","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570917885?lang=en_us&edition=fundamental","pubTime":"2025-09-26 20:34","pubTimestamp":1758890089,"startTime":"0","endTime":"0","summary":"Amneal Pharmaceuticals (AMRX) said Friday it submitted a biologics license application for a proposed biosimilar to Kashiv BioSciences-developed Xolair, a registered trademark of Novartis (NVS), with ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BJT1NW94.SGD","AMRX","BK4578","IE0002141913.USD","IE00B4R5TH58.HKD","LU0070302665.USD","BK4585","IE0009355771.USD","BK4588","BK4007","BK4532","IE00B2B36J28.USD","LU0211331839.USD","LU0208291251.USD","LU0320765489.SGD","IE00BFTCPJ56.SGD","NVS","IE00BJJMRZ35.SGD"],"gpt_icon":0},{"id":"2570883121","title":"Novartis Says Won't be Impacted by 100% Tariff on Branded Pharmaceutical Products","url":"https://stock-news.laohu8.com/highlight/detail?id=2570883121","media":"MT Newswires Live","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570883121?lang=en_us&edition=fundamental","pubTime":"2025-09-26 20:16","pubTimestamp":1758888971,"startTime":"0","endTime":"0","summary":"Novartis  said Friday that the newly announced 100% tariff on branded or patented pharmaceutical products will not impact it as it continues to advance its plan to ensure key medicines for US patients are manufactured locally.The statement comes after US President Donald Trump said that a 100% tariff would be imposed on branded or patented pharmaceutical products unless the owning company is building a manufacturing plant in the country.\"Our $23 billion investment in US-based infrastructure continues to progress as we work to ensure all key Novartis medicines for US patients will be made in the United States,\" the drugmaker said in an emailed statement to MT Newswires.\"We have ongoing construction and expect to announce five new sites to be under construction before end of year. We are well prepared with product supply in the US through mid-2026,\" the company also said.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","IE0002141913.USD","NVS","BK4578","IE00BJT1NW94.SGD","BK4588","IE0009355771.USD","LU0070302665.USD","LU0208291251.USD","LU0211331839.USD","BK4532","LU0320765489.SGD","BK4007","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","BK4585"],"gpt_icon":0},{"id":"2570470070","title":"U.S. Tariffs Pose Limited Risk to Big Swiss Pharma Groups -- Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2570470070","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2570470070?lang=en_us&edition=fundamental","pubTime":"2025-09-26 16:05","pubTimestamp":1758873900,"startTime":"0","endTime":"0","summary":"0805 GMT - President Trump's drug tariffs will have a limited impact on big Swiss pharma players given their U.S. presence, Vontobel analysts write. While there is broad room for interpretation of Trump's announcement, Roche and Novartis are shielded by their U.S. footprints, while Sandoz should be unaffected since it focuses on exempted generic products, the analysts say. Galderma's exposure is less clear as it has a smaller U.S. presence. Tariffs will increase U.S. drug prices and supply concerns, but they shouldn't threaten the country's leading position in drug production, Vontobel says. Galderma shares fall 3.2%, with Roche and Novartis down 0.3% and 0.2%, respectively. Sandoz shares trade broadly flat. ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","RHHBY","IE00BFTCPJ56.SGD","IE00BJT1NW94.SGD","03165","LU0211331839.USD","BK4532","BK4585","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","BK4578","LU0320765489.SGD","BK4007","IE00B4R5TH58.HKD","LU0208291251.USD","LU0070302665.USD","NVS","BK4588","IE0009355771.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":1,"totalSize":166,"code":"91000000","status":"200"}]}}